Lamya

Desogestrel, the active ingredient in Lamya, is a progestin presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering the endometrium. GNH USA supplies Lamya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desogestrel is a progestin used in oral contraceptive therapy to prevent pregnancy.

Prevention of pregnancy: Inhibits ovulation and creates endometrial changes that prevent implantation, providing reliable contraception for women of child‑bearing potential.

Desogestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or abdominal discomfort - Headache or migraine - Breast tenderness - Irregular menstrual bleeding - Mood changes or depression - Weight gain or fluid retention

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Severe allergic reaction (anaphylaxis) - Liver dysfunction or jaundice - Visual disturbances or eye problems

Before prescribing Desogestrel, clinicians should evaluate patient history and risk factors. - Smoking: Advise against smoking, especially in women over 35, due to increased thrombotic risk. - Cardiovascular disease: Avoid in patients with history of stroke, myocardial infarction, or uncontrolled hypertension. - Liver disease: Use with caution in patients with hepatic impairment. - Pregnancy: Not indicated for use during pregnancy; discontinue if pregnancy occurs. - Store at ambient temperature: Keep below 25 °C, in original packaging, protected from moisture and direct sunlight.

Desogestrel may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antiepileptic drugs (e.g., carbamazepine, phenytoin): May reduce contraceptive effectiveness. - Rifampin or other potent enzyme inducers: Can markedly decrease plasma levels of desogestrel.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): May increase hormone levels, raising side‑effect risk. - Antiretroviral therapy (e.g., protease inhibitors): May affect hormone metabolism. - St. John’s wort: May modestly lower contraceptive efficacy. - Certain antibiotics (e.g., griseofulvin): Potentially reduce effectiveness, though evidence is limited.